(MedPage Today) -- Two recent deaths tied to counterfeit versions of retatrutide, an investigational weight-loss medication, were reported to the FDA. (CBS News)
Meanwhile, ongoing lawsuits allege that GLP-1 receptor agonists can cause severe...
The U.S. Food and Drug Administration (FDA) has received reports in recent months that two people have died after taking illegal versions of an experimental weight-loss drug, according to documents reviewed by CBS News. The reports link the deaths to products claiming to contain retatrutide, a drug being developed by Eli Lilly that has not yet been approved by the FDA, CBS News reported. Federal law prohibits the commercial sale of unapproved dr…